Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?

Walker BR.

Growth Horm IGF Res. 2001 Jun;11 Suppl A:S91-5. Review.

PMID:
11527096
2.
3.

Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.

Stewart PM, Toogood AA, Tomlinson JW.

Horm Res. 2001;56 Suppl 1:1-6. Review.

PMID:
11786677
5.

Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.

Walker BR, Andrew R.

Ann N Y Acad Sci. 2006 Nov;1083:165-84. Review.

PMID:
17148739
6.

Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.

Stimson RH, Walker BR.

Minerva Endocrinol. 2007 Sep;32(3):141-59. Review.

PMID:
17912154
7.

Tissue-specific dysregulation of cortisol metabolism in human obesity.

Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR.

J Clin Endocrinol Metab. 2001 Mar;86(3):1418-21.

PMID:
11238541
8.

11beta-hydroxysteroid dehydrogenase type 1 and obesity.

Morton NM, Seckl JR.

Front Horm Res. 2008;36:146-64. doi: 10.1159/0000115363. Review.

PMID:
18230901
9.

[Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome].

Góth M, Hubina E, Korbonits M.

Orv Hetil. 2005 Jan 9;146(2):51-5. Review. Hungarian.

PMID:
15724952
10.

Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.

Tomlinson JW, Stewart PM.

Best Pract Res Clin Endocrinol Metab. 2001 Mar;15(1):61-78. Review.

PMID:
11469811
11.

Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.

Rask E, Walker BR, Söderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, Olsson T.

J Clin Endocrinol Metab. 2002 Jul;87(7):3330-6.

PMID:
12107245
12.

Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.

Westerbacka J, Yki-Järvinen H, Vehkavaara S, Häkkinen AM, Andrew R, Wake DJ, Seckl JR, Walker BR.

J Clin Endocrinol Metab. 2003 Oct;88(10):4924-31.

PMID:
14557475
13.
14.

11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.

Tomlinson JW.

Minerva Endocrinol. 2005 Mar;30(1):37-46. Review.

15.

Obesity and cortisol.

Björntorp P, Rosmond R.

Nutrition. 2000 Oct;16(10):924-36. Review.

PMID:
11054598
16.

The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.

Tomlinson JW, Stewart PM.

Horm Metab Res. 2002 Nov-Dec;34(11-12):746-51. Review.

PMID:
12660893
17.

Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.

Seckl JR, Morton NM, Chapman KE, Walker BR.

Recent Prog Horm Res. 2004;59:359-93. Review.

PMID:
14749510
18.

Effects of cortisol and oestradiol on hepatic 11beta-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor proteins in late-gestation sheep fetus.

Gupta S, Alfaidy N, Holloway AC, Whittle WL, Lye SJ, Gibb W, Challis JR.

J Endocrinol. 2003 Feb;176(2):175-84.

19.

Insulin attenuates the stimulatory effects of tumor necrosis factor alpha on 11beta-hydroxysteroid dehydrogenase 1 in human adipose stromal cells.

Handoko K, Yang K, Strutt B, Khalil W, Killinger D.

J Steroid Biochem Mol Biol. 2000 Mar;72(3-4):163-8.

PMID:
10775808

Supplemental Content

Support Center